Document:

NuVox, Inc. Form S-8 Exhibit 4.12

Exhibit 4.12

NON-QUALIFIED STOCK OPTION AGREEMENT

UNDER
NUVOX, INC.
2001 STOCK
INCENTIVE PLAN

        THIS NON-QUALIFIED STOCK OPTION AGREEMENT
 ("Agreement"), made as of the _____th day of _______, 2001 ("Date of
Grant"), by and between NuVox, Inc. a Delaware corporation (hereinafter called the "Company"), and ____________________________ (herein
called "Optionee");

        WITNESSETH THAT:

        WHEREAS,
the Board of Directors of the Company (“Board of Directors”) adopted
the NuVox, Inc. 2001 Stock Incentive Plan (“Plan”) on ___________,
2001, pursuant to which shares of Series F Preferred Stock of the Company were
reserved for issuance under the Plan in the form of stock option grants; and 

        WHEREAS,
the Company desires to grant to Optionee a non-qualified stock option under the
Plan, which will not qualify as an incentive stock option within the meaning of
Section 422 of the Internal Revenue Code of 1986, as amended; 

        NOW, THEREFORE,
 in consideration of the premises, and of the mutual agreements hereinafter set forth, it is
covenanted and agreed as follows:

        1.        
Grant of Option.      Pursuant to action of the Compensation
Committee (“Committee”) appointed by the Board of Directors to
administer the Plan, which action was taken effective as of the Date of Grant,
the Company grants to Optionee a non-qualified stock option (“Option”)
to purchase all or any part of ______________ shares of Series F Preferred Stock
of the Company, par value $0.01 per share (“Series F Preferred”), at a
purchase price of $_________ per share, subject to the terms and conditions set
forth herein. This Option is not intended to be, and will not be treated as, an
incentive stock option within the meaning of Section 422 of the Internal
Revenue Code of 1986, as amended. 

        2.        
Grant Subject to Plan.     
  This Option is granted under, and is expressly subject to, all of the terms and
provisions of the Plan, which terms are incorporated herein by reference.

        3.        
Term of Option.      To the extent exercisable pursuant to Section 4 hereof, this Option may be exercised only
during the "Option Term," which shall commence on the Date of Grant and shall expire on the earlier of: (a) the tenth anniversary of
the Date of Grant and (b) the date required by Subsection 6.7(d) of the Plan.

        4.        
Exercise of Option.      This Option may be exercised, in whole or in
part, during the Option Term only to the extent this Option has become
exercisable pursuant to Subsection 6.6 or 6.7 of the Plan and only to the extent
it has not expired or been forfeited pursuant to Subsection 6.7 of the Plan. 

        5.        
Anti-Dilution Provisions.      In the event that, during the
term of this Agreement, there is any change in the outstanding shares of Series
F Preferred of the Company by reason of stock dividends, recapitalizations,
mergers or consolidations in which the outstanding shares of Series F Preferred
are exchanged for other securities or assets of the Company or another entity,
split-ups, combinations or exchanges of shares and the like, the number of
shares of Series F Preferred covered by this Agreement, and the exercise price
set forth in Section 1 hereof, shall be adjusted, so that Optionee shall be
entitled to receive, upon exercise of the Option hereby granted, the number of
shares of Series F Preferred or other securities or assets which Optionee would
have been entitled to receive following such event if the Option hereby granted
had been exercised immediately prior to such event or any record date with
respect thereto. 

        6.        
Compliance With Laws and Regulations.     Notwithstanding anything
herein to the contrary, no shares of Series F Preferred subject to this Option
shall be issued by the Company pursuant to the exercise of this Option unless
such issuance and exercise complies with all relevant provisions of law. 

        7.        
Execution of Additional Documents; Legends.      Optionee agrees, at
the time of exercise by Optionee of the Option hereby granted, or any part
thereof, to execute an Instrument of Accession to Stockholders’ Agreement,
an Instrument of Accession to Registration Rights Agreement and an Instrument of
Accession to Shareholders Agreement in the forms attached as Exhibits A, B
and C hereto, respectively. Optionee also agrees that the certificates
evidencing the shares acquired by Optionee on exercise of all, or any part of,
the Option hereby granted may, if deemed appropriate by the Committee, bear
restrictive legends referencing any applicable federal or state securities law
restrictions and the transfer restrictions imposed pursuant to the forms
attached as Exhibits A, B and C hereto. 

        8.        
Non-Transferability.      Neither the Option hereby granted nor
any rights under this Agreement may be assigned, transferred or in any manner
encumbered except by will or the laws of descent and distribution, and any
attempted assignment, transfer, mortgage, pledge or encumbrance except as herein
authorized, shall be void and of no effect. The Option hereby granted may be
exercised during Optionee’s lifetime only by Optionee. 

        9.        
Shares Issued on Exercise of Option.       It is the intention of the Company that on any exercise of the Option
granted hereby it will transfer to Optionee shares of Series F Preferred to satisfy its obligations to deliver shares on any exercise
hereof.

        10.        
Stockholder Rights.     Optionee shall not have any stockholder rights
with respect to shares of Series F Preferred subject to this Option until
Optionee has exercised this Option in accordance with a method prescribed by the
Committee and Optionee has received a duly issued stock certificate representing
the shares of Series F Preferred for which this Option was exercised. 

2

        11.        
Committee Administration.      The Option granted hereby has
been granted pursuant to a determination made by the Committee, and the
Committee, subject to the express terms of this Agreement, shall have plenary
authority to interpret any provision of this Agreement and to make any
determinations necessary or advisable for the administration of this Agreement
and the exercise of the rights herein granted, and may waive or amend any
provisions hereof in any manner not adversely affecting the rights granted to
Optionee by the express terms hereof. 

        12.        
Governing Law.     To the extent federal law does not otherwise control, this Agreement, and the transactions
contemplated hereby, shall be governed by the laws of the State of Delaware, without regard to its conflicts of laws principles.

        13.        
No Right to Continued Employment.       Nothing in this Agreement shall be deemed to create any limitation or
restriction on such rights as the Company otherwise would have to terminate the employment of Optionee at any time for any reason.

        14.        
Binding Effect.     This Agreement shall be binding upon, and inure to
the benefit of, the Company and its successors and assigns and Optionee and
Optionee’s legal representatives, heirs, legatees, distributees, assigns
and transferees by operation of law, whether or not any such person shall have
become a party to this Agreement. 

        15.        
Withholding Taxes.     The Company shall have the right to
deduct or withhold, or require Optionee to remit to the Company, any amount
sufficient to satisfy the federal, state and local taxes required by law to be
withheld with respect to any taxable event arising as a result of this Option. 

3

        IN
WITNESS WHEREOF, the Company has caused this Agreement to be executed on its
behalf and to be attested under the seal of the Company, pursuant to due
authorization, and Optionee has signed this Agreement to evidence acceptance of
the Option herein granted and of the terms hereof, all as of the date hereof. 

	 	NUVOX, INC.

	 	By:	

	ATTEST:

	  	 
	
	 	 
	[Name]
Assistant Secretary	  	 
	 	

	  	[First Name, Last Name]

4

Exhibit A

Instrument of Accession to Stockholders’ Agreement

        Reference
is made to that certain Amended and Restated Stockholders’ Agreement dated
as of March 31, 2000 (as amended and in effect from time to time, the
“Stockholders’ Agreement”), among NuVox, Inc., a Delaware
corporation (the “Company”), and the Stockholders (as defined therein)
of the Company. 

        The
undersigned, in order to become the owner or holder of ___________ shares (the
“Shares”) of Series F Preferred, $0.01 par value per share, of the
Company (“Series F Preferred”), hereby agrees that by the
undersigned’s execution hereof (a) the undersigned is a Stockholder
party to the Stockholders’ Agreement subject to all of the rights,
restrictions, conditions and obligations applicable to Stockholders set forth in
the Stockholders’ Agreement, and (b) all of such Shares of Series F
Preferred constitute Stock subject to all the rights, restrictions, conditions
and obligations applicable to Stock as set forth in the Stockholders’
Agreement. This Instrument of Accession shall take effect and shall become a
part of said Stockholders’ Agreement immediately upon execution. 

        Executed
as of the date set forth below under the laws of the State of Delaware. 

	  	  	Signature:

	

	  	  	Address:

 	

	  	  	 	

	  	  	 	

	  	  	Date: 	
 
	Accepted:

 	  	  
	NUVOX, INC.

	  	  
	By:

	

 	  	  
	Date:	
 	  	  

Exhibit B

Instrument
of Accession to Registration Rights Agreement

        Reference
is made to that certain Amended and Restated Registration Rights Agreement dated
as of March 31, 2000 (as amended and in effect from time to time, the
“Registration Rights Agreement”), among NuVox, Inc., a Delaware
corporation (the “Company”), and the Stockholders (as defined therein)
of the Company. 

        The
undersigned, in order to become the owner or holder of ___________ shares (the
“Shares”) of Series F Preferred, $0.01 par value per share, of the
Company (“Series F Preferred”), hereby agrees that by the
undersigned’s execution hereof (a) the undersigned is a Stockholder
party to the Registration Rights Agreement subject to all of the rights,
restrictions, conditions and obligations applicable to Stockholders set forth in
the Registration Rights Agreement, and (b) all of such Shares of Series F
Preferred constitute Restricted Securities subject to all the rights,
restrictions, conditions and obligations applicable to Restricted Securities as
set forth in the Registration Rights Agreement. This Instrument of Accession
shall take effect and shall become a part of said Registration Rights Agreement
immediately upon execution. 

        Executed
as of the date set forth below under the laws of the State of Delaware. 

	  	  	Signature:

	

	  	  	Address:

	

	  	  	 	

	  	  	 	

	  	  	Date: 	
 
	Accepted:

 	  	  
	NUVOX, INC.

	  	  
	By:

	

 	  	  
	Date:	
 	  	  

Exhibit C

Instrument
of Accession

        Reference
is made to that certain Shareholders Agreement dated as of August 14, 1998,
as amended as of November 18, 1998 and December 13, 1999, a copy of which
is attached hereto (as amended and in effect from time to time, the
“Shareholders’ Agreement”), among NuVox, Inc., a Delaware
corporation (the “Company”), and the Shareholders of the Company (as
defined therein). 

        The
undersigned, in order to become the owner or holder of ________________ shares
(the “Shares”) of the Series F Preferred, $0.01 par value per share,
of the Company, hereby agrees that by the undersigned’s execution hereof
(a) the undersigned is an Employee Shareholder party to the Shareholders
Agreement subject to all of the restrictions, conditions and obligations
applicable to Employee Shareholders set forth in the Shareholders Agreement, and
entitled to all of the rights and benefits of an Employee Shareholder
thereunder, and (b) all of the Shares (and any and all shares of stock of
the Company issued in respect thereof) are subject to all the restrictions,
conditions and obligations applicable to, and entitled to all of the rights and
benefits of, Shares as set forth in the Shareholders Agreement. This Instrument
of Accession shall take effect and shall become a part of the Shareholders
Agreement immediately upon execution. 

        Executed
as of the date set forth below under the laws of the State of Missouri. 

	  	  	Signature:

	

	  	  	Address:

	

	  	  	 	

	  	  	 	

	  	  	Date: 	
 
	Accepted:

 	  	  
	NUVOX, INC.

	  	  
	By:

	

 	  	  
	Date:Exhibit 4.13

Exhibit 4.13

NEITHER THESE SERIES D
WARRANTS NOR THE SHARES OF SERIES D PREFERRED STOCK ISSUABLE UPON EXERCISE OF
THESE WARRANTS HAVE BEEN REGISTERED UNDER ANY STATE SECURITIES ACT. NEITHER
THESE SERIES D WARRANTS NOR THE SHARES OF SERIES D PREFERRED STOCK ISSUABLE UPON
EXERCISE OF THESE WARRANTS CAN BE SOLD OR TRANSFERRED EXCEPT PURSUANT TO THE
REGISTRATION PROVISIONS OF THE SECURITIES ACT OF 1933, AS AMENDED
(“SECURITIES ACT”) AND ANY APPLICABLE STATE SECURITIES ACT, OR
PURSUANT TO AN EXEMPTION THEREFROM. THESE SERIES D WARRANTS AND THE SHARES OF
SERIES D PREFERRED STOCK ISSUABLE UPON EXERCISE HEREOF ARE SUBJECT TO CERTAIN
RESTRICTIONS ON TRANSFER AS DESCRIBED HEREIN AND THE NUVOX, INC. 2001 STOCK
INCENTIVE PLAN. 

	No.________ 	Series D Warrants

VOID AFTER
AUGUST 31, 2006

NUVOX, INC.

SERIES D
WARRANT CERTIFICATE

THIS CERTIFIES THAT,
for good and valuable consideration, the receipt of which is hereby
acknowledged, ___________________, his or her permitted transferees or registered
assigns, in accordance with the terms of this Series D Warrant Certificate (the
“Warrant Certificate”), and the NuVox, Inc. 2001 Stock Incentive Plan
(the “Plan”) is the owner of the number of Series D Warrants set forth
above, each of which entitles the owner thereof to acquire from NuVox, Inc., a
Delaware corporation (the “Company”), subject to the terms of this
Warrant Certificate and the Plan, upon presentation and surrender of this
Warrant Certificate with the Form of Election to Purchase attached hereto duly
executed, at any time prior to the Expiration Date (as defined below), at the
principal executive offices of the Company located at 16090 Swingley Ridge Road,
Suite 500, Chesterfield, Missouri 63017, one fully paid and nonassessable share
of Series D Convertible Preferred Stock, $.01 par value (“Series D
Preferred Stock”) of the Company at the purchase price of $1.50 per share
(“Purchase Price”), payable in cash, certified check or wire transfer,
by “Cashless Exercise” or “Net Issue Exercise” both as
provided below. The “Expiration Date” shall be the earlier of (a) 4:00
P.M. (St. Louis time) on August 31, 2006, or (b) subject to receipt of the
Offering Notice (as defined below) by the holder of this Warrant Certificate,
the closing of the sale of the common stock of the Company, $.01 par value
(“Common Stock”), in a firm commitment, underwritten public offering
registered under the Securities Act of 1933, as amended (the “Securities
Act”), other than a registration relating solely to a transaction under
Rule 145 under the Securities Act (or any successor thereto) or to an employee
benefit plan of the Company, at a public offering price (prior to
underwriters’ discounts and expenses) equal to or exceeding $1.00 per share
of Common Stock (as adjusted for any stock dividends, combinations or splits
with respect to the Common Stock), in which the aggregate proceeds to 

the
Company and/or any selling stockholders (prior to underwriters’ discounts
and expenses) are at least $50 million (a “Qualified Public
Offering”). The Company shall provide written notice (the “Offering
Notice”) to the holder of this Warrant Certificate of the proposed closing
date of a Qualified Public Offering (the “Closing Date”) not later
than 10 days prior to the actual Closing Date. Upon receipt of the Offering
Notice, the holder of this Warrant Certificate, upon surrender of this Warrant
Certificate with the Form of Election to Purchase attached hereto duly executed,
may exercise the Series D Warrants evidenced hereby conditioned upon the closing
of the Qualified Public Offering described in the Offering Notice (a
“Conditional Exercise”). If the Qualified Public Offering does not
close within 30 days of such proposed Closing Date, the Series D Warrants
evidenced hereby shall remain outstanding and this Warrant Certificate shall be
returned to the holder hereof, subject to its prior expiration in accordance
with clause (a) above unless such expiration date shall have passed during the time
the Warrant Certificate had been tendered in anticipation of the Qualified
Public Offering, in which case the holder of this Warrant Certificate will be
given 20 business days to exercise the Series D Warrants evidenced hereby. 

        The holder of this Warrant Certificate may, at its option and at any time prior to the Expiration Date,
exercise the Series D Warrants by "Cashless Exercise" and pay the Purchase Price by delivering to the Company
cash and/or shares of Common Stock, shares of any series of preferred stock of the Company or other securities
(other than the Series D Warrants evidenced hereby) issued by the Company having a "Market Price" equal to the
amount of the Purchase Price provided that any shares of Company stock tendered must have been owned by the
holder hereof for at least six months. As used herein, the term "Market Price" of any security means the average
of the closing sales prices of such security on all securities exchanges on which such security may at the time
be listed, or, if there has been no sale on any such exchange on any day, the average of the highest bid and
lowest asked prices on all such exchanges at the end of such day, or, if on any day such security is not so
listed, the average of the representative bid and asked prices quoted in the NASDAQ System as of 4:00 P.M., New
York time, or, if on any day such security is not quoted in the NASDAQ System, the average of the highest bid and
lowest asked prices on such day in the domestic over-the-counter market as reported by the National Quotation
Bureau, Incorporated, or any similar successor organization, in each such case averaged over a period of 21 days
consisting of the day as of which "Market Price" is being determined and the 20 consecutive business days prior
to such day; provided, however, that, if at any time such security is not listed on any securities exchange or
quoted in the NASDAQ System or the over-the-counter market, the "Market Price" shall be the fair value thereof
determined jointly by the Company and the holder of this Warrant Certificate.  If such parties are unable to
reach agreement within a reasonable period of time, such fair value shall be determined by an independent
appraiser experienced in valuing securities jointly selected by the Company and the holder of this Warrant
Certificate.  The determination of such appraiser shall be final and binding upon the parties, and the Company
shall pay the fees and expenses of such appraiser.  No fractional shares of Series D Preferred Stock will be
issued upon exercise of the Series D Warrants evidenced hereby. The Company shall, in lieu of issuing any
fractional share, pay the holder entitled to such fraction a sum in cash equal to such fraction multiplied by the
then effective Purchase Price.

2

        In addition,  the holder of this Warrant  Certificate has the option,  at any time prior to the Expiration
Date, to Net Issue  Exercise this Warrant  Certificate in accordance  with the  provisions of this section.  If the
fair market value of one share of the  Company's  Series D Preferred  Stock is greater than the Purchase  Price (at
the date of  calculation  as set forth below),  in lieu of exercising  this Warrant  Certificate  for cash or other
Company  securities,  the holder of this Warrant  Certificate  may elect a Net Issue Exercise  pursuant to which it
will  receive  shares of Series D  Preferred  Stock  equal to the  number  of  shares of Series D  Preferred  Stock
computed using the following formula:

	  	X =  	Y (A-B) 

	  	 	A

	Where: 	X = the number of shares of Series D Preferred Stock to be issued to the holder of the
exercised Warrant Certificate; 
	 	Y = the number of shares of Series D Preferred Stock purchasable under the Warrant Certificate
or, if only a portion of the Warrant Certificate is being exercised, the portion of the Warrant
Certificate being exercised (at the date of such exercise); 
	 	A = the fair market value of one share of the Company's Series D Preferred Stock (at the date
of such exercise); and 
	 	B = Purchase Price (as adjusted to the date of such exercise). 

        A Net Issue Exercise shall be made by presentation and surrender of this Warrant Certificate with the
Form of Election to Purchase in substantially the form attached hereto properly executed at the executive offices
of the Company, or at such other location as the Company may advise the holder of this Warrant Certificate in
writing.

        For purposes of the above calculation, the fair market value of one share of Series D Preferred Stock
shall be based upon the Market Price (as set forth above).

        The
Company agrees that the shares of Series D Preferred Stock purchased upon
the exercise of this Warrant Certificate shall be and are deemed to be issued to
the holder of the exercised Warrant Certificate as the record owner of such
shares of Series D Preferred Stock as of the close of business on the date
on which this Warrant Certificate with the Form of Election to Purchase in
substantially the form attached hereto properly executed and appropriate payment
for such shares of Series D Preferred Stock shall have each been delivered
to the Company at its principal executive offices (other than with respect to a
Net Issue Exercise where no payment is required). Certificates for the shares of
Series D Preferred Stock so purchased, together with any other securities
or property to which the holder of the exercised Warrant Certificate is entitled
upon such exercise, shall be delivered to such holder by the Company at the
Company’s expense within a reasonable time after the rights represented by
this Warrant Certificate have been so exercised, and in any event, within ten (10) business days after such exercise.

3

In case of a purchase of less than all
of the shares which may be purchased under this Warrant Certificate, the Company
shall cancel this Warrant Certificate and execute and deliver a new Warrant
Certificate or Warrant Certificates of like tenor for the balance of the shares
of Series D Preferred Stock purchasable under the Warrant Certificate
surrendered upon such purchase to the holder of the exercised Warrant
Certificate within a reasonable time but no later than ten (10) business days
after such exercise. Each stock certificate so delivered shall be in such
denominations of Series D Preferred Stock as may be requested by the holder
of the exercised Warrant Certificate and shall be registered in the name of such
holder. 

        The
Series D Warrants evidenced by this Warrant Certificate are part of a series of
duly authorized Series D Warrants issued or to be issued under the Plan and
pursuant to the terms of a Securities Purchase Agreement by and among the
Company and the Purchasers of Units, dated as of August __, 2001 (the
“Purchase Agreement”) and are referred to hereinafter as the
“Series D Warrants.” 

        In
order to prevent dilution of the exercise rights granted under this Warrant
Certificate, the Purchase Price shall be subject to adjustment from time to time
as follows: 

        For purposes of determining the adjusted Purchase Price, the following adjustment provisions shall be
applicable:

        
(a)  Subdivision or Combination of Series D Preferred Stock.  If the Company at any time subdivides (by
any stock split, stock dividend, recapitalization or otherwise) its outstanding shares of Series D Preferred
Stock into a greater number of shares, the Purchase Price in effect immediately prior to such subdivision shall
be proportionately reduced, and, conversely, if the Company at any time combines (by reverse stock split or
otherwise) its outstanding shares of Series D Preferred Stock into a smaller number of shares, the Purchase Price
in effect immediately prior to such combination shall be proportionately increased.

        
(b)  Reorganization, Reclassification, Consolidation, Merger or Sale.  Any reorganization,
reclassification, consolidation, merger, sale of all or substantially all of the Company's assets to another
Person (as defined below) or other transaction which is affected in such a manner that holders of Series D
Preferred Stock are entitled to receive (either directly or upon subsequent liquidation) stock, securities,
assets or other property with respect to or in exchange for Series D Preferred Stock is referred to herein as an
"Organic Change".  Prior to the consummation of, and as a condition to, any Organic Change, the Company shall make
lawful and appropriate provision to insure that the holder of this Warrant Certificate shall thereafter have the
right to acquire and receive, in lieu of or in addition to (as the case may be) the shares of Series D Preferred
Stock immediately theretofore acquirable and receivable upon the exercise of the Series D Warrants, such shares
of stock, securities, assets or other property as such holder would have received in connection with such Organic
Change if the holder of this Warrant Certificate had exercised the Series D Warrants immediately prior to such
Organic Change.  In each such case, the Company shall also make appropriate provision to insure that the
adjustment provisions of this Warrant Certificate shall thereafter continue to apply (including, without
limitation, provisions for adjustment to the Purchase Price and of the number of shares purchasable and
receivable upon exercise of the Series D Warrants).  The Company shall not effect any consolidation, merger or
sale, unless 

4

prior to the consummation thereof, the successor entity (if other than the Company) resulting from
such consolidation or merger or the entity purchasing such assets or stock assumes, by written instrument
executed and mailed or delivered to the holder hereof at the last address of such holder appearing on the books
of the Company, the obligation to deliver to the holder of this Warrant Certificate such shares of stock,
securities, assets or other property as, in accordance with the foregoing provisions, such holder may be entitled
to acquire.

        (c)  Certain Events.  If any event occurs of the type contemplated by the adjustment provisions of this
Warrant Certificate but not expressly provided for by such provisions (including, without limitation, the
granting of stock appreciation rights, phantom stock rights or other rights with equity features), then the
Company's board of directors shall make an appropriate and lawful adjustment in the Purchase Price so as to
protect the rights of the holder of this Warrant Certificate; provided that no such adjustment shall increase the
Purchase Price as otherwise determined pursuant hereto or decrease the number of shares of Series D Preferred
Stock issuable upon exercise of the Series D Warrants.

        (d)  Notices.  Immediately upon any adjustment of the Purchase Price, the Company shall give written
notice thereof to the holder of this Warrant Certificate, setting forth in reasonable detail and certifying the
calculation of such adjustment.  The Company shall also give written notice to the holder of this Warrant
Certificate at least 20 days prior to the date on which the Company closes its books or takes a record (I) with
respect to any dividend or distribution upon the Series D Preferred Stock, (II) with respect to any pro rata
subscription offer to holders of the Series D Preferred Stock or (III) for determining rights to vote with
respect to any Organic Change, dissolution or liquidation, and the date on which any Organic Change, dissolution
or liquidation shall take place.

        (e)  Purchase Rights.  If at any time the Company grants, issues or sells any options, convertible
securities or rights to purchase stock, warrants, securities or other property (the "Purchase Rights") pro rata
to each record holder of the Series D Preferred Stock, in his or her capacity as such record holder, then the
holder of this Warrant Certificate shall thereafter be entitled to acquire, in addition to the shares of Series D
Preferred Stock acquirable and receivable upon exercise of the Series D Warrants, and upon the terms applicable
to such Purchase Rights, the aggregate Purchase Rights which such holder could have acquired if such holder had
held the number of shares of Series D Preferred Stock acquirable upon exercise of the Series D Warrants
immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights,
or, if no such record is taken, the date as of which the record holders of Series D Preferred Stock are to be
determined for the grant, issue or sale of such Purchase Rights.

        The
Company covenants and agrees that it will at all times (i) have authorized and
reserved and keep available out of its authorized but unissued Series D
Preferred Stock, solely for the purpose of issuance upon the exercise of the
Series D Warrants, such number of shares of Series D Preferred Stock as shall
from time to time be issuable upon the exercise of the Series D Warrants and
(ii) reserve and keep available out of its authorized but unissued Common Stock,
solely for the purpose of issuance upon the conversion of the shares of Series D
Preferred Stock issuable upon the exercise of the Series D Warrants, such number
of shares of Common Stock as shall from time to time be issuable upon conversion
of such shares of Series D Preferred Stock issuable on the exercise of the
Series D

5

Warrants; and if at any time the number of authorized but unissued and issued but not outstanding shares of the Series D Preferred Stock and the Common Stock, on a fully diluted basis, shall not be sufficient to effect such exercise
or such conversion based on the Purchase Price then in effect, the Company will
take such corporate action as may, in the opinion of its counsel, be necessary
to increase its authorized but unissued or issued but not outstanding shares of
the Series D Preferred Stock or its Common Stock, as applicable, to such number
of shares as shall be sufficient for such purpose. The Company further covenants
that all shares of Series D Preferred Stock and Common Stock which shall be so
issuable, when issued upon exercise of the Series D Warrants or on conversion of
such Series D Preferred Stock, as the case may be, shall be duly authorized,
validly issued, fully-paid and non-assessable and free of all taxes, liens, and
charges with respect to the issue thereof. 

        The
issuance of certificates for shares of the Series D Preferred Stock upon the
exercise of the Series D Warrants shall be made without charge to the holder
hereof for cost incurred by the Company in connection with such exercise and the
related issuance of shares of Series D Preferred Stock. 

        No
holder of this Warrant Certificate shall be entitled to vote or receive
dividends or be deemed the holder of Series D Preferred Stock or any other
securities of the Company which may at any time be issuable on the exercise
hereof for any purpose, nor shall anything contained herein be construed to
confer upon the holder hereof, as such, any of the rights of a shareholder of
the Company or any right to vote for the election of directors or upon any
matter submitted to stockholders at any meeting thereof, or to give or withhold
consent to any corporate action (whether upon any recapitalization, issue of
stock, reclassification of stock, change of par value, consolidation, merger,
conveyance, or otherwise), or except as provided above, to receive notice of
meetings, or to receive dividends of subscription rights or otherwise, until the
Series D Warrant or Warrants evidenced by this Warrant Certificate shall have
been exercised. No provisions hereof, in the absence of affirmative action by
the holder to purchase shares of Series D Preferred Stock, and no mere
enumeration herein of the rights or privileges of the holder hereof, shall give
rise to any liability of such holder for the Purchase Price or as a shareholder
of the Company, whether such liability is asserted by the Company or by its
creditors. 

        Every
holder of this Warrant Certificate by accepting the same consents and agrees
with the Company that: 

             (a)  Neither this Warrant Certificate nor any rights hereunder may be assigned, transferred, pledged or
hypothecated in any way (whether by operation of law or otherwise) without the express prior written consent of
the Company, which consent will be given at the Company's sole discretion; provided, however, that, the holder
hereof may transfer this Warrant Certificate and the rights hereunder by gift to Family Members (as defined
below) of such holder without such consent, provided that such transfer is not inconsistent with the Form S-8
rules pertaining to the transfer of options.  This Warrant Certificate shall not be subject to execution,
attachment or similar process.  Any attempted assignment, transfer, pledge, hypothecation or other disposition of
this Warrant Certificate or the rights hereunder contrary to the provisions hereof shall be null and void and
without legal effect;

             (b)  This Warrant Certificate, if transferred in accordance with paragraph (a), above, is transferable
only on the registry books of the Company if surrendered at the principal office of the Company, duly endorsed,
or accompanied by a proper instrument of transfer;

6

             (c)  The Company may deem and treat the person in whose name the Warrant Certificate is registered on
the registry books of the Company as the absolute owner thereof and of the Series D Warrants evidenced thereby
(notwithstanding any notations of ownership or writing on the Warrant Certificates made by anyone other than the
Company) for all purposes whatsoever, and the Company shall not be affected by any notice to the contrary;

             (d)  If the Series D Warrants are exercised at any time prior to the closing of a Qualified Public
Offering, the holder hereof shall, prior to the delivery of any shares of Series D Preferred Stock which may be
purchased upon exercise hereof, execute and deliver to the Company instruments of accession providing that the
holder of such shares shall become a party to, and shall be subject to the terms and conditions of, the Amended
and Restated Stockholders' Agreement dated as of March 31, 2000 and amended from time to time thereafter, including as of _____ __, 2001, by and among
the Company and its stockholders, the Amended and Restated
Registration Rights Agreement dated as of March 31, 2000 and amended from time to time thereafter, including as of _____ __, 2001, by and among the
Company and its stockholders, and, to the extent such holder is an employee of the Company, the Amended and Restated Shareholders Agreement dated as of August 14, 1998 and amended from time to time; thereafter, including as of ______ __, 2001, by and among the Company and its stockholders; and

             (e)  In the event of the exercise of the Series D Warrants, the holder hereof intends to purchase the
shares purchased upon exercise hereof for investment purposes only and not with a view to resale or other
distribution; except the Company, at its election, may waive or release this condition in the event the shares
purchased upon such exercise are registered under the Securities Act, or upon the happening of any other
contingency which the Company shall determine warrants the waiver or release of this condition. The holder hereof
also agrees that the certificates evidencing the shares purchased upon exercise of the Series D Warrants may bear
restrictive legends, if appropriate, referencing any applicable federal or state securities law restrictions and
the transfer restrictions imposed pursuant to the documents described in clause (d) above, which legends may be
in such forms as the Company shall reasonably determine to be proper.

             As used herein, the term "Family Members" shall mean any Person considered a "family member" under the
General Instructions to Form S-8.

        As
used herein, the term “Person” shall mean an individual, partnership,
corporation, association, trust, joint venture, unincorporated organization, and
any government, governmental department or agency or political subdivision
thereof. 

        All
notices, demands and other communications provided for hereunder shall be in
writing and shall be deemed to have been given when delivered personally to the
recipient, one business day after being sent to the recipient by reputable
express courier service (charges prepaid) or three business days after being
mailed to the recipient by certified or registered mail, return receipt
requested and postage prepaid. Such notices, demands and other communications
shall be delivered or sent (i) to the Company at its principal executive offices
and (ii) to the holder of this Warrant Certificate at its address as it appears
on the Company’s records (or such other address as may be indicated by the
holder of this Warrant Certificate upon written notice to the Company). 

7

        THESE
WARRANTS, THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER AND ANY CLAIMS AND
DISPUTES RELATING THERETO, SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN
ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, WITHOUT REGARD TO ITS
CONFLICTS OF LAWS PRINCIPLES THAT WOULD CAUSE THE LAWS OF ANY JURISDICTION OTHER
THAN THE STATE OF DELAWARE TO BE APPLIED. 

        Any
legal action or proceeding with respect to this Warrant Certificate may be
brought in the courts of the City of St. Louis, State of Missouri, or of
the United States of America for the Eastern District of Missouri in
St. Louis, Missouri, and, by execution and issuance or acceptance of this
Warrant Certificate, the Company and the holder of this Warrant Certificate
hereby accepts for itself and in respect of its property, irrevocably and
unconditionally, the jurisdiction of the aforesaid courts. The Company and the
holder of this Warrant Certificate further irrevocably consents to the service
of process out of any of the aforementioned courts in any action or proceeding
by the mailing of copies thereof by registered or certified mail, postage
prepaid, to the Company at its principal executive offices and to the holder of
this Warrant Certificate at its address as it appears on the Company’s
records (or such other address as may be indicated by the holder of this Warrant
Certificate upon written notice to the Company), such service to become
effective seven days after such mailing. Nothing herein shall affect the right
of the Company or the holder of this Warrant Certificate to serve process in any
other manner permitted by law or to commence legal proceedings or otherwise
proceed in any other jurisdiction. The Company and the holder of this Warrant
Certificate further hereby irrevocably waives any objection which it may now or
hereafter have to the laying of venue of any of the aforesaid actions or
proceedings arising out of or in connection with this Warrant Certificate
brought in the courts referred to above and hereby further irrevocably waives
and agrees not to plead or claim in any such court that any such action or
proceeding brought in any such court has been brought in an inconvenient forum. 

             IN WITNESS WHEREOF, the Company has caused this Warrant Certificate to be executed and issued by its duly
authorized officer as of _____ __, 2001.

	 	NUVOX, INC.

	  	By:_________________________________

ATTEST:

8

FORM OF
ELECTION TO PURCHASE

                       (To be executed if holder desires to exercise the Warrant Certificate.)

To NuVox, Inc.
	[   ] 	  	The undersigned hereby irrevocably elects to exercise 
	  	[   ] 	by cash payment of the aggregate Purchase Price 
	  	[   ] 	by "Cashless Exercise" by delivering securities equal to the Market Value
         of the aggregate Purchase Price
	  	[   ] 	by "Net Issue Exercise"

	 	
the
number of the Series D Warrants to purchase the shares of Series D Preferred
Stock issuable upon the exercise of such Series D Warrants as set forth below,
and requests that certificates for such shares be issued in the name of:

	 

	(Please print name and address)
	 
	 

	(social security or other identifying number)
	 
	 

	(number of warrants exercised)

	[   ] 	  	The
undersigned hereby irrevocably elects, subject to and conditioned upon the
closing of a Qualified Public Offering on the Closing Date in accordance with
the terms of this Warrant Certificate, to exercise
	  	[   ] 	by cash payment of the aggregate Purchase Price 
	  	[   ] 	by "Cashless Exercise" by delivering securities equal to the Market Value
         of the aggregate Purchase Price
	  	[   ] 	by "Net Issue Exercise"

	 	
the
number of the Series D Warrants to purchase the shares of Series D Preferred
Stock issuable upon the exercise of such Series D Warrants as set forth below,
and requests that certificates for such shares be issued in the name of:

	 

	(Please print name and address)
	 
	 

	(social security or other identifying number)
	 
	 

	(number of warrants exercised)

	Dated: ____________________, _____ 	 	 
	 	 	
Signature
	 	 	
(Signature must conform in all respects to name of holder as
specified on the face of this Warrant Certificate)

FORM OF ASSIGNMENT

(To
be executed by the registered holder if such holder desires 
to transfer
the Warrant Certificate.)

	 

	hereby irrevocably transfers unto
	  
	 

	this Warrant Certificate, together with all right, title and interest therein, and does hereby irrevocably
constitute and appoint
	  
	 

	attorney in fact for the
undersigned to transfer the within Warrant Certificate on the books of the
within-named Company, with full power of substitution. The undersigned warrants
that the transfer reflected by this document is a gift, and the undersigned has
received no consideration in return for the transfer. 

	Dated: ____________________, _____ 	 	 
	 	 	
Signature
	 	 	
(Signature must conform in all respects to name of holder as
specified on the face of this Warrant Certificate)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00029-of-00352.parquet"}]]